Kurarinone Attenuates LPS‐Induced Pneumonia by Inhibiting MAPK and NF‐κB Signaling Pathways
APMIS · 2025
DOI: 10.1111/apm.70013 ↗Kurz gefasst
Fachartikel in der Zeitschrift APMIS, 2025. Verfasst von Lili Wang und 4 weiteren Autor:innen. Beteiligte Einrichtung: Department of Emergency Medicine, The First Affiliated Hospital of Bengbu Medical University, Bengbu, China. Hauptthemen laut MEDLINE: NF-kappa B, Pneumonia, Signal Transduction, Flavonoids. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 60 Literaturangaben.
Abstract (Originalsprache)
Kurarinone is a prenylated flavanone isolated from Sophora flavescens Aiton. This investigation aimed to elucidate whether kurarinone could ameliorate lipopolysaccharide (LPS)‐induced pneumonia and explore the underlying mechanism. C57BL/6 mice were treated with LPS (50 μg/20 μL) to establish pneumonia models. Kurarinone (100 mg/kg) or dexamethasone (DEX, 5 mg/kg) was administered for 7 days before LPS inhalation. BEAS‐2B cells were incubated with kurarinone at 1, 2, and 5 μM for 2 h before LPS stimulation for 24 h. We found that kurarinone ameliorated lung injury and inflammatory cell infiltration in the mouse lung ( p < 0.001). Kurarinone decreased MPO activity (47.6%, p < 0.001) and alleviated the inflammatory response by reducing the levels of IL‐1β (34.9%, p < 0.001), TNF‐α (55.1%, p < 0.001), and IL‐6 (36.2%, p < 0.001) in the lung. Kurarinone reduced the levels of IL‐1β, TNF‐α, IL‐6, iNOS, and COX2 in LPS‐treated BEAS‐2B cells in a concentration‐dependent manner ( p < 0.05). Mechanistically, kurarinone restrained LPS‐induced activation of MAPK and NF‐κB pathways in vivo and in vitro ( p < 0.05). Overall, kurarinone alleviates LPS‐induced pneumonia in mice by reducing inflammation via MAPK and NF‐κB pathways, suggesting that kurarinone might be a potential therapeutic agent for pneumonia. This study provides new research ideas for the discovery of natural flavonoids that can treat pneumonia.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Emergency Medicine, The First Affiliated Hospital of Bengbu Medical University, Bengbu, China.
- Department of Urology, The First Affiliated Hospital of Bengbu Medical University, Bengbu, China.
ORCID-Profile: Changyuan Dai
Zitieren
APA
Wang, L., Lu, G., Wang, F., Tao, Y., & Dai, C. (2025). Kurarinone Attenuates LPS‐Induced Pneumonia by Inhibiting MAPK and NF‐κB Signaling Pathways. APMIS. https://doi.org/10.1111/apm.70013
Vancouver
Wang L, Lu G, Wang F, Tao Y, Dai C. Kurarinone Attenuates LPS‐Induced Pneumonia by Inhibiting MAPK and NF‐κB Signaling Pathways. APMIS. 2025. doi:10.1111/apm.70013
BibTeX
@article{Wang2025,
author = {Wang, Lili and Lu, Guoyu and Wang, Fangli and Tao, Yanyan and Dai, Changyuan},
title = {Kurarinone Attenuates LPS‐Induced Pneumonia by Inhibiting MAPK and NF‐κB Signaling Pathways},
journal = {APMIS},
year = {2025},
doi = {10.1111/apm.70013}
}
EUVIMED